{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:41:30Z","timestamp":1760150490943,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Programa 2 (PREVICET)","award":["PI18\/01751","2021\/SGR 00702"],"award-info":[{"award-number":["PI18\/01751","2021\/SGR 00702"]}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Science and Innovation, Institute of Health Carlos III","doi-asserted-by":"publisher","award":["PI18\/01751","2021\/SGR 00702"],"award-info":[{"award-number":["PI18\/01751","2021\/SGR 00702"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa)","award":["PI18\/01751","2021\/SGR 00702"],"award-info":[{"award-number":["PI18\/01751","2021\/SGR 00702"]}]},{"DOI":"10.13039\/501100003030","name":"Catalan Agency for the Management of Grants for University","doi-asserted-by":"publisher","award":["PI18\/01751","2021\/SGR 00702"],"award-info":[{"award-number":["PI18\/01751","2021\/SGR 00702"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>In countries with low tuberculosis (TB) incidence, the systematic testing and treatment of latent TB infection (LTBI) in contacts of pulmonary TB index cases is the standard of care. The objective of this study, conducted in Catalonia over 2019\u20132021, was to assess the factors associated with LTBI treatment prescription to close contacts of pulmonary TB index cases. In this population-based epidemiological study of LTBI prevalence among pulmonary TB contacts between 2019 and 2021, multiple logistic backward stepwise regression was used to identify the factors associated with treatment prescription, for which the adjusted odds ratio (aOR) and 95% confidence intervals (CI) were calculated. A total of 1487 LTBI contacts of 542 pulmonary TB index cases were studied, 80.6% of whom received a prescription. The factors associated with LTBI treatment prescription were exposure \u22656 h\/day (aOR 14.20; 95% CI 5.22\u201338.66) and exposure &lt;6 h\/day (aOR 7.32, 95% CI 2.48\u201321.64), whereas the factors associated with no LTBI treatment prescription were age \u226555 years (aOR 0.22, 95% CI 0.08\u20130.64) and bacillus Calmette\u2013Guerin vaccination (aOR 0.38, 95% CI 0.16\u20130.90). Crucial to LTBI treatment prescription is information on the contact\u2019s duration of exposure to pulmonary TB, not only for contacts exposed for \u22656 h\/day, but also for contacts with lower daily exposure levels.<\/jats:p>","DOI":"10.3390\/vaccines11121800","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T08:36:59Z","timestamp":1701419819000},"page":"1800","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors Associated with Treatment Prescription to Pulmonary Tuberculosis Contacts in Catalonia (2019\u20132021): A Population-Based Epidemiological Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0219-1907","authenticated-orcid":false,"given":"\u00c1ngela","family":"Dom\u00ednguez","sequence":"first","affiliation":[{"name":"Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-5325","authenticated-orcid":false,"given":"N\u00faria","family":"Soldevila","sequence":"additional","affiliation":[{"name":"Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-9238","authenticated-orcid":false,"given":"Diana","family":"Toledo","sequence":"additional","affiliation":[{"name":"Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-0236","authenticated-orcid":false,"given":"Ignasi","family":"Parr\u00f3n","sequence":"additional","affiliation":[{"name":"Ag\u00e8ncia de Salut Publica de Catalunya, 08005 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-2459","authenticated-orcid":false,"given":"Joan-Pau","family":"Millet","sequence":"additional","affiliation":[{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"},{"name":"Ag\u00e8ncia de Salut P\u00fablica de Barcelona, 08023 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Barrabeig","sequence":"additional","affiliation":[{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"},{"name":"Ag\u00e8ncia de Salut Publica de Catalunya, 08005 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2896-7286","authenticated-orcid":false,"given":"Pere","family":"Godoy","sequence":"additional","affiliation":[{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"},{"name":"Institut de Recerca Biom\u00e9dica de Lleida (IRBLleida), 25198 Lleida, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of Transmission of Tuberculosis in Catalonia (Spain) Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022). Global Tuberculosis Report 2022."},{"key":"ref_2","unstructured":"World Health Organization (2023, February 04). WHO End TB Strategy 2015. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2015.19."},{"key":"ref_3","unstructured":"Heymann, D.L. (2022). Control of Communicable Disease Manual, American Public Health Association. [21st ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2015.11.017","article-title":"Risk of active tuberculosis in the five years following infection","volume":"149","author":"Trauer","year":"2016","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: A systematic review and metaanalysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur. Resp. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2023.3954","article-title":"Screening for latent tuberculosis infection in adults updated evidence report and systematic review for the US Preventive Services Task Force","volume":"329","author":"Jonas","year":"2023","journal-title":"JAMA"},{"key":"ref_8","unstructured":"World Health Organization (2015). Guidelines on the Management of Latent Tuberculosis Infection."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1183\/09031936.00201609","article-title":"Tuberculosis contact investigation in low prevalence countries: A European consensus","volume":"36","author":"Erkens","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/jiy265","article-title":"Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis","volume":"218","author":"Reichler","year":"2018","journal-title":"Infect. Dis."},{"key":"ref_11","unstructured":"Mendioroz, J., Peque\u00f1o, S., and L\u00f3pez, M. (2021). La tuberculosi a Catalunya l\u2019any 2019, Subdirecci\u00f3 General de Vigil\u00e0ncia i Resposta a Emerg\u00e8ncies de Salut P\u00fablica."},{"key":"ref_12","unstructured":"L\u00f3pez, M., Mart\u00ednez, H., Peque\u00f1o, S., and Sicart, E. (2022). Situaci\u00f3 Epidemiol\u00f2gica i Tend\u00e8ncia de L\u2019end\u00e8mia Tuberculosa a Catalunya, 2020, Subdirecci\u00f3 General de Vigil\u00e0ncia i Resposta a Emerg\u00e8ncies de Salut P\u00fablica."},{"key":"ref_13","unstructured":"L\u00f3pez, M., Mart\u00ednez, H., Peque\u00f1o, S., and Sicart, E. (2023). La Tuberculosi a Catalunya L\u2019any 2021, Subdirecci\u00f3 General de Vigil\u00e0ncia i Resposta a Emerg\u00e8ncies de Salut P\u00fablica."},{"key":"ref_14","unstructured":"Barrabeig-Fabregat, I., Clotet, L., Godoy, P., Merc\u00e8, R., Orcau-Palau, A., Parr\u00f3n, I., Rod\u00e9s-Monegal, A., Sabater, M., and Torra-Bastardas, R. (2016). Recomanacions per a la Realitzaci\u00f3 D\u2019estudis de Contactes de Malalts amb Tuberculosi a Catalunya, Secretaria de Salut P\u00fablica."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care diagnosed and treatment of latent tuberculosis infection: A systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1473-3099(17)30004-X","article-title":"Unwarranted prescription variations for treatment of latent tuberculosis infection","volume":"17","author":"Dobler","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sullivan, K., Pease, C., Zwerling, A., Mallick, R., Van Dyk, D., Mulpuru, S., Allen, C., Alsdurf, H., and Alvarez, G.G. (2021). Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-10733-9"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dobler, C.C., Luu, Q., and Marks, G.B. (2013). What patient factors predict physicians\u2019 decision not to treat latent tuberculosis infection in tuberculosis contacts?. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076552"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10903-022-01438-1","article-title":"Can primary care drive tuberculosis elimination? Increasing latent tuberculosis infection testing and treatment initiation at a community health center with a large non-U.S.-born population","volume":"25","author":"Tang","year":"2023","journal-title":"J. Immigr. Minor. Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pulmoe.2020.12.001","article-title":"Latent tuberculosis infection prevalence in second generation immigrants from high to low TB burden countries","volume":"29","author":"Shlomi","year":"2023","journal-title":"Pulmonology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e023412","DOI":"10.1136\/bmjopen-2018-023412","article-title":"Immigrant screening for latent tuberculosis infection: Numbers needed to test and treat, a Norwegian population-based cohort","volume":"9","author":"Winje","year":"2019","journal-title":"BMJ Open"},{"key":"ref_22","first-page":"858","article-title":"Tuberculosis surveillance among new immigrants in Montreal","volume":"9","author":"Richards","year":"2005","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.arbres.2022.12.011","article-title":"Latent tuberculosis infection treatment: Compliance and factors related with initiation","volume":"59","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sangma, V.S.C., Jaggi, S., Saini, V., Aggarwal, D., Kumar, P., and Chander, J. (2023). Prevalence of latent tuberculosis infection in the household contacts of pulmonary tuberculosis, time to treat. Monaldi Arch. Chest Dis., ahead of print.","DOI":"10.4081\/monaldi.2023.2563"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/eurpub\/ckac031","article-title":"Impact of COVID-19 pandemic on contact tracing of patients with pulmonary tuberculosis","volume":"32","author":"Godoy","year":"2022","journal-title":"Eur. J. Public Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1164\/ajrccm.162.6.2004022","article-title":"Outcomes of contact investigations of infectious tuberculosis patients","volume":"162","author":"Marks","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stockbridge, E.L., Miller, T.L., Carlson, E.K., and Ho, C. (2018). Predictors of latent tuberculosis infection treatment completion in the US private sector: An analysis of administrative claims. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-5578-3"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez, G.G., VanDyk, D.D., Aaron, S.D., Cameron, D.W., Davies, N., Stephen, N., Mallick, R., Momoli, F., Moreau, K., and Obed, N. (2014). TAIMA (Stop) TB: The impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100975"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Han, S.S., Lee, S.J., Yim, J.J., Song, J.H., and Kang, Y.A. (2019). Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0222810"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/occmed\/kqad036","article-title":"Healthcare worker\u2019s acceptance of and adherence to latent tuberculosis treatment","volume":"73","author":"Yang","year":"2023","journal-title":"Occup. Med."},{"key":"ref_31","unstructured":"Grupo de trabajo Plan Prevenci\u00f3n y Control de la Tuberculosis (2019). Plan para la Prevenci\u00f3n y Control de la Tuberculosis en Espa\u00f1a. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud, Ministerio de Sanidad, Consumo y Bienestar Social."},{"key":"ref_32","unstructured":"(2015). Decret 2013\/2015, de 15 de setembre, pel qual es crea la Xarxa de Vigil\u00e0ncia Epidemiol\u00f2gica i es regulen els sistemes de notificaci\u00f3 de malalties de declaraci\u00f3 obligat\u00f2ria i els brots epid\u00e8mics. DOGC, 6958, 1\u201319."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/12\/1800\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:02Z","timestamp":1760132162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/12\/1800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["vaccines11121800"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11121800","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}